litlas
Log inCreate account

Peter A. Jones

Active 1975–2025

198
Papers
79,475
Citations
131
h-index
197
i10-index

Citations

Citations per year for Peter A. Jones1948: 2 citations1975: 4 citations1976: 5 citations1977: 5 citations1978: 14 citations1979: 9 citations1980: 33 citations1981: 33 citations1982: 93 citations1983: 94 citations1984: 110 citations1985: 68 citations1986: 67 citations1987: 68 citations1988: 60 citations1989: 78 citations1990: 87 citations1991: 124 citations1992: 115 citations1993: 141 citations1994: 165 citations1995: 201 citations1996: 182 citations1997: 236 citations1998: 203 citations1999: 363 citations2000: 372 citations2001: 361 citations2002: 494 citations2003: 542 citations2004: 488 citations2005: 597 citations2006: 660 citations2007: 738 citations2008: 721 citations2009: 809 citations2010: 949 citations2011: 926 citations2012: 810 citations2013: 836 citations2014: 867 citations2015: 733 citations2016: 769 citations2017: 833 citations2018: 681 citations2019: 2,093 citations2020: 1,831 citations2021: 1,897 citations2022: 1,347 citations2023: 1,028 citations2024: 1,425 citations2025: 682 citations2026: 22 citations1949–1974: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 8,299 citing papers, 32.1% of this breakdownChina: 3,003 citing papers, 11.6% of this breakdownUnited Kingdom: 1,610 citing papers, 6.2% of this breakdownGermany: 1,463 citing papers, 5.7% of this breakdownCanada: 898 citing papers, 3.5% of this breakdownJapan: 866 citing papers, 3.4% of this breakdownItaly: 864 citing papers, 3.4% of this breakdownFrance: 779 citing papers, 3% of this breakdownSpain: 728 citing papers, 2.8% of this breakdownAustralia: 652 citing papers, 2.5% of this breakdownNetherlands: 505 citing papers, 2% of this breakdownIndia: 448 citing papers, 1.7% of this breakdown
0%32.1%Other 22.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology65.7%
  • Medicine24.2%
  • Immunology and Microbiology3.2%
  • Agricultural and Biological Sciences2.3%
  • Neuroscience1%
  • Environmental Science1%
  • Other2.6%

Topics

  • Epigenetics and DNA Methylation16.7%
  • RNA modifications and cancer5.6%
  • Cancer-related gene regulation4.6%
  • Genomics and Chromatin Dynamics3.3%
  • Histone Deacetylase Inhibitors Research2.8%
  • Cancer Genomics and Diagnostics2%
  • Other65%

Coauthors

All papers

Open in search
  1. Functions of DNA methylation: islands, start sites, gene bodies and beyond

    Authors: Peter A. Jones - Nature Reviews Genetics 2012 cited by 6,240

  2. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts

    Authors: David Roulois, Helen Loo Yau, Rajat Singhania, Yadong Wang, Arnavaz Danesh, Shu Yi Shen, Han Han, Gangning Liang, Peter A. Jones, Trevor J. Pugh, Catherine O′Brien, Daniel D. De Carvalho - Cell 2015 cited by 1,557

  3. Epigenetic Determinants of Cancer

    Authors: Stephen B. Baylin, Peter A. Jones - Cold Spring Harbor Perspectives in Biology 2016 cited by 1,342

  4. The Epigenomics of Cancer

    Authors: Peter A. Jones, Stephen B. Baylin - Cell 2007 cited by 4,469

  5. A decade of exploring the cancer epigenome — biological and translational implications

    Authors: Stephen B. Baylin, Peter A. Jones - Nature reviews. Cancer 2011 cited by 2,864

  6. Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer

    Authors: Xiaojing Yang, Han Han, Daniel D. De Carvalho, Fides D. Lay, Peter A. Jones, Gangning Liang - Cancer Cell 2014 cited by 1,246

  7. Epigenetics in human disease and prospects for epigenetic therapy

    Authors: Gerda Egger, Gangning Liang, Ana M. Aparicio, Peter A. Jones - Nature 2004 cited by 3,231

  8. The fundamental role of epigenetic events in cancer

    Authors: Peter A. Jones, Stephen B. Baylin - Nature Reviews Genetics 2002 cited by 5,661

  9. Targeting the cancer epigenome for therapy

    Authors: Peter A. Jones, Jean‐Pierre J. Issa, Stephen B. Baylin - Nature Reviews Genetics 2016 cited by 1,139

  10. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

    Authors: Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill, Wendy A. Kellner, Alexandra Stowell, Christian Sherk, Kristen Wong, Sarath Pathuri, Jacques Briand, Michael Steidel, P Chapman, Arthur Groy, Ashley K. Wiseman, Charles F. McHugh, Nino Campobasso, Alan P. Graves, Emma Fairweather, Thilo Werner, Ali Raoof, Roger J. Butlin, Lourdes Rueda, J.R. Horton, David T. Fosbenner, Cunyu Zhang, Jessica L. Handler, Morris Muliaditan, Makda Mebrahtu, Jon‐Paul Jaworski, Dean E. McNulty, Charlotte Burt, H. Christian Eberl, Amy Taylor, Thau Ho, Susan Merrihew, Shawn W. Foley, Anna Rutkowska, Mei Li, Stuart P. Romeril, Kristin Goldberg, Xing Zhang, Christopher S. Kershaw, Marcus Bantscheff, Anthony J. Jurewicz, Elisabeth A. Minthorn, Paola Grandi, Mehul Patel, Andrew B. Benowitz, Helai P. Mohammad, Aidan G. Gilmartin, Rab K. Prinjha, Donald Ogilvie, Christopher Carpenter, Dirk A. Heerding, Stephen B. Baylin, Peter A. Jones, Xiaodong Cheng, Bryan W. King, Juan I. Luengo, Allan M. Jordan, Ian D. Waddell, Ryan G. Kruger, Michael T. McCabe - Nature Cancer 2021 cited by 280

  11. Epigenetic therapy in immune-oncology

    Authors: Peter A. Jones, Hitoshi Ohtani, Ankur Chakravarthy, Daniel D. De Carvalho - Nature reviews. Cancer 2019 cited by 553

  12. The Role of DNA Methylation in Mammalian Epigenetics

    Authors: Peter A. Jones, Daiya Takai - Science 2001 cited by 2,131

  13. Cellular differentiation, cytidine analogs and DNA methylation

    Authors: Peter A. Jones, Shirley M. Taylor - Cell 1980 cited by 1,860

  14. Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

    Authors: Jueng Soo You, Peter A. Jones - Cancer Cell 2012 cited by 1,152

  15. DNA methylation enables transposable element-driven genome expansion

    Authors: Wanding Zhou, Gangning Liang, Peter L. Molloy, Peter A. Jones - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 198

  16. The Epigenetic Hallmarks of Cancer

    Authors: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin - Cancer Discovery 2024 cited by 133

  17. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules

    Authors: Theresa K. Kelly, Yaping Liu, Fides D. Lay, Gangning Liang, Benjamin P. Berman, Peter A. Jones - Genome Research 2012 cited by 481

  18. Epigenetic modifications as therapeutic targets

    Authors: Theresa K. Kelly, Daniel D. De Carvalho, Peter A. Jones - Nature Biotechnology 2010 cited by 796

  19. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation

    Authors: Tina Branscombe Miranda, Connie C. Cortez, Christine B. Yoo, Gangning Liang, Masanobu Abe, Theresa K. Kelly, Víctor E. Márquez, Peter A. Jones - Molecular Cancer Therapeutics 2009 cited by 597

  20. Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy

    Authors: Tae Gun Kang, Xin Lan, Mi Tian, Hongfeng Chen, Shanta Alli, Song-Eun Lim, Sheetal Bhatara, Anoop Babu Vasandan, Grace Ward, Sofía Bentivegna, Josh Jang, Marianne Spatz, Jin‐Hwan Han, Balthasar Schlotmann, Jakob S. Jespersen, Christopher DeRenzo, Peter Vogel, Jiyang Yu, Stephen B. Baylin, Peter A. Jones, Casey L. O’Connell, Kirsten Grønbæk, Ben Youngblood, Caitlin C. Zebley - Science 2024 cited by 80

  21. Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study

    Authors: Roisín M. Connolly, Huili Li, Rachel C. Jankowitz, Zhe Zhang, Michelle A. Rudek, Stacie C. Jeter, Shannon A. Slater, Penny Powers, Antonio C. Wolff, John H. Fetting, Adam Brufsky, Richard Piekarz, Nita Ahuja, Peter W. Laird, Hui Shen, Daniel J. Weisenberger, Leslie Cope, James G. Herman, George Somlo, Agustin A. García, Peter A. Jones, Stephen B. Baylin, Nancy E. Davidson, Cynthia A. Zahnow, Vered Stearns - Clinical Cancer Research 2016 cited by 159

  22. Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers

    Authors: Huili Li, Katherine B. Chiappinelli, Angela A. Guzzetta, Hariharan Easwaran, Ray-Whay Chiu Yen, Rajita Vatapalli, Michael J. Topper, Jianjun Luo, Roisín M. Connolly, Nilofer S. Azad, Vered Stearns, Drew M. Pardoll, Nancy E. Davidson, Peter A. Jones, Dennis J. Slamon, Stephen B. Baylin, Cynthia A. Zahnow, Nita Ahuja - Oncotarget 2014 cited by 439

  23. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

    Authors: H. Josh Jang, Galen Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue, Justin R. Kulchycki, Ryan S. Burgos, Mahvish Tafseer, R. Katherine Alpaugh, Candice L. Schwebel, Rutika Kokate, Daniel M. Geynisman, Matthew R. Zibelman, Pooja Ghatalia, Peter W. Nichols, Woonbok Chung, Jozef Madžo, Noah M. Hahn, David I. Quinn, Jean‐Pierre J. Issa, Michael J. Topper, Stephen B. Baylin, Hui Shen, Kerry S. Campbell, Peter A. Jones, Elizabeth R. Plimack - Clinical Cancer Research 2023 cited by 37

  24. Epigenetic therapy of cancer: past, present and future

    Authors: Christine B. Yoo, Peter A. Jones - Nature Reviews Drug Discovery 2006 cited by 1,288